Group 1 - The core viewpoint of the article highlights Huaxia Eye Hospital's current stock performance, with a closing price of 19.24 yuan, an increase of 1.21%, and a rolling PE ratio of 38.26 times, with a total market value of 16.162 billion yuan [1] - The average PE ratio for the medical services industry is 41.42 times, with a median of 44.32 times, placing Huaxia Eye Hospital at the 28th position in the industry ranking [1] - As of the first quarter of 2025, 18 institutions hold shares in Huaxia Eye Hospital, including 10 funds and 8 other entities, with a total holding of 192.8128 million shares valued at 3.843 billion yuan [1] Group 2 - Huaxia Eye Hospital's main business is specialized ophthalmic medical services, with key products including cataract projects, posterior segment projects, refractive projects, and comprehensive optometry projects [1] - The latest performance report for the first quarter of 2025 shows the company achieved an operating income of 1.093 billion yuan, a year-on-year increase of 11.74%, and a net profit of 150 million yuan, reflecting a year-on-year decrease of 4.00%, with a gross profit margin of 44.97% [1]
华厦眼科收盘上涨1.21%,滚动市盈率38.26倍,总市值161.62亿元